a developer of drugs to combat various diseases
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GLESX | 15.35 | 0.12 | +0.79% |
GS Energy Infrastructure Fd R6 Shares | |||
CCMMX | 10.02 | N/A | N/A |
Conestoga Mid Cap Investors | |||
MFWHX | 17.83 | -0.05 | -0.28% |
MFS Global Total Return R3 | |||
BOGIX | 33.09 | -0.39 | -1.16% |
SGI Small Cap Core Fund I Shares | |||
PCAOX | 83.49 | -1.20 | -1.42% |
Principal Capital Appreciation R3 |
A.I.dvisor tells us that GALT and SNPX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GALT and SNPX's prices will move in lockstep.
Ticker / NAME | Correlation To GALT | 1D Price Change % | ||
---|---|---|---|---|
GALT | 100% | +0.73% | ||
SNPX - GALT | 32% Poorly correlated | -8.05% | ||
RNAC - GALT | 32% Poorly correlated | +1.82% | ||
CDXC - GALT | 27% Poorly correlated | -5.28% | ||
RNAZ - GALT | 27% Poorly correlated | -2.92% | ||
ERAS - GALT | 26% Poorly correlated | -4.98% | ||
More |